Abiopharma

🔍 Rennick Charles D (Executive)

Company: TechTarget, Inc. (TTGT)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Acquired 7,864 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: M | equity_swap_involved: false | shares_owned_after: 39,144.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 7,864 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-13 | Code: M | equity_swap_involved: false | shares_owned_after: 7,864.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4
• Acquired 60,392 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: A | equity_swap_involved: false | shares_owned_after: 60,392.00 | transaction_form_type: 4 | Footnotes: F2, F5, F5

Footnotes:

• F1: This transaction represents the settlement of restricted stock units ("RSUs") in shares of common stock on their scheduled vesting date.
• F2: Each RSU represents a contingent right to receive one share of TechTarget, Inc.'s ("Informa TechTarget") Common Stock upon vesting.
• F3: Includes 1,582 shares of Common Stock acquired through the Informa TechTarget 2024 Employee Stock Purchase Plan.
• F4: This award was granted on August 13, 2024. One-third of the RSUs subject to the award vested on each of August 13, 2025 and August 13, 2026, and one-third of the RSUs are scheduled to vest on August 13, 2027. Vested shares will be delivered to the Reporting Person on the applicable dates as set forth in the Reporting Person's award agreement with respect to each vesting tranche.
• F5: The RSU grant vests in equal tranches, one-third per year on each anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the applicable dates as set forth in the Reporting Person's award agreement with respect to each vesting tranche.
• REMARKS: Mr. Rennick is the Vice President, General Counsel, and Corproate Secretary of Informa TechTarget.